ArticleThoracic cancer2021

PD-L1 and CD47 co-expression predicts survival and enlightens future dual-targeting immunotherapy in non-small cell lung cancer.

Zhenlin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.